Shalini Sharp is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 994 shares of NBIX, which is worth approximately $127,450. The most recent transaction as insider was on May 17, 2024, when has been sold 1,106 shares (Common Stock) at a price of $141.9 per share, resulting in proceeds of $156,941. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 994
0% 3M change
n/a 12M change
Total Value Held $127,450

Shalini Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
SELL
Open market or private sale
$156,941 $141.9 p/Share
1,106 Reduced 52.67%
994 Common Stock
May 17 2024
BUY
Exercise of conversion of derivative security
-
2,100 Added 50.0%
2,100 Common Stock

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
DTIL
PRECISION BIOSCIENCES INC Healthcare
NUVB
Nuvation Bio Inc. Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
STRO
SUTRO BIOPHARMA, INC. Healthcare
OGN
Organon & Co. Healthcare
BGNE
BeiGene, Ltd. Healthcare
SS

Shalini Sharp

Director
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX